title: Clinical efficacy of amoxycillin/clavulanate in laparoscopically confirmed salpingitis.
abstract: To test the efficacy and safety of amoxycillin/clavulanate (Augmentin), 102 hospital patients with laparoscopically confirmed acute salpingitis were treated with parenteral amoxycillin/clavulanate (1.2 g qid for three days) followed by oral amoxycillin/clavulanate (two tablets of 625 mg tid for a further six days). Bacteriological samples were obtained from the cervix uteri and the pouch of Douglas. One hundred patients were assessable for clinical outcome using several variables including pain scores. Amoxycillin/clavulanate alone was effective in 95 patients (95%). Three patients (3%) responded to amoxycillin/clavulanate with marked improvement but another antibiotic was subsequently added to their treatment regimen. Treatment failed in two patients. At follow-up two weeks after hospital discharge, three patients (3.8%) had relapsed or were re-infected. Adverse drug events included one case of drug fever, one case of rash and one case of severe diarrhoea. Treatment was stopped in all three cases. Gastrointestinal reactions, mainly mild diarrhoea, were seen in 31 patients. No clinically relevant changes in haematological or clinical chemical indices were attributable to the amoxycillin/clavulanate treatment. We conclude that amoxycillin/clavulanate is a clinically effective and safe treatment for acute salpingitis.
authors.affiliation: University Hospital, Department of Gynaecology, Zürich, Switzerland.
authors.forename: J
authors.initials: J
authors.lastname: Obwegeser
authors.forename: J
authors.initials: J
authors.lastname: Kunz
authors.forename: J
authors.initials: J
authors.lastname: Wüst
authors.forename: G
authors.initials: G
authors.lastname: Schär
authors.forename: R
authors.initials: R
authors.lastname: Steiner
authors.forename: W
authors.initials: W
authors.lastname: Büchi
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019980:Amoxicillin-Potassium Clavulanate Combination; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004906:Erythrocyte Count; D005260:Female; D006801:Humans; D010535:Laparoscopy; D007958:Leukocyte Count; D008875:Middle Aged; D012488:Salpingitis / Q000188:drug therapy*
chemical_list: D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin